CURRENT APPROACHES TO THE TREATMENT OF METABOLOC SYNDROME IN PATIENTS WITH ENDOMETARIAL HYPERPLASIA AND CANCER
https://doi.org/10.21294/1814-4861-2016-15-5-73-81
Abstract
The literature review deals with the problem of metabolic correction of hormonal-metabolic disturbances in patients with endometrial hyperplasia (EH) and endometrial cancer (EC) occurring concurrently with metabolic syndrome. Along with a conventional treatment, metabolic syndrome correction for EH and EC patients is expected to contribute to the reduction in the risk of recurrent EC. The development of new methods for predicting EH outcome as well as options for metabolic rehabilitation of these patients is required.
About the Authors
A. L. Chernyshova
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia 5, Kooperativny Street, 634009-Tomsk, Russia
Russian Federation
Russian Federation
MD, DSc, Principal Investigator, Ginecology Department, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Tomsk, Russian Federation)
L. A. Kolomiets
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia 5, Kooperativny Street, 634009-Tomsk, Russia
Russian Federation
Russian Federation
DSc, Professor, Honored Science Worker of Russian Federation, Head of Gynecology Department, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Tomsk, Russian Federation)
T. V. Saprina
Siberian State Medical University, Tomsk, Russia
Russian Federation
Russian Federation
MD, DSc, Professor, Department of Endocrinology and Diabetology, Siberian State Medical University (Tomsk, Russian Federation)
O. E. Gonchikova
Siberian State Medical University, Tomsk, Russia
Russian Federation
Russian Federation
Physician, Department of Endocrinology and Diabetology, Siberian State Medical University (Tomsk, Russian Federation)
T. Yu. Koshchevets
Tomsk City Hospital № 3, Tomsk, Russia
Russian Federation
Endocrinologist, Tomsk City Hospital № 3 (Tomsk, Russian Federation)
Russian Federation
Endocrinologist, Tomsk City Hospital № 3 (Tomsk, Russian Federation)
References
1. Bershtein L.М. Hormonal carcinogenesis. St. Petersburg; 2000, 199 p. [in Russian]
2. Manukhin I.B., Tumilovich L.G., Gevorkyan М.А. Clinical lectures on gynecological endocrinology. Moscow; 2001, 247p. [in Russian]
3. Alexandrovsky Ya.А. the molecular relationship between of diabetes mellitus and endometrial cancer. Scientific and clinical aspects. Biochemistry. 2002; 67 (12): 1611–1631. [in Russian]
4. Cannata D., Fierz Y., Vijayakumar A., LeRoith D. Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med. 2010 Mar-Apr; 77 (2): 197–213. doi: 10.1002/msj.20167.
5. Larsson S.C., Wolk A. Diabetes mellitus and incidence of kidney cancer: a meta- analysis of cohort studies. Diabetologia. 2011 May; 54 (5): 1013–8. doi: 10.1007/s00125-011-2051-6.
6. Larsson S.C., Mantzoros C.S., Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007 Aug 15; 121 (4): 856–62.
7. Li D., Tang H., Hassan M.M., Holly E.A., Bracci P.M., Silverman D.T. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control. 2011 Feb; 22 (2): 189–97. doi: 10.1007/s10552-010-9686-3.
8. Berstein L.M. Age, environmental factors, and hormonal carcinogenesis. Problems in Oncology. 2001; 47 (2): 148–155. [in Russian]
9. Bershtein L.М. Endocrine oncology: traditions, modernity and prospects. St.Petersburg; 2004, 340 p. [in Russian]
10. Antsifirov М.B. Obesity. Metaboloc syndrome. Diabetes mellitus type 2. Moscow; 2000: 53–61. [in Russian]
11. Vasilyev D.А., Semenova N.V., Bershtein L.М. Diabetes mellitus, impaired glucose tolerance and malignancies: risk assessment. Russian Journal of Oncology. 2007; 3: 25–28. [in Russian]
12. Artymuk N.V., Gulyaeva L.F., Ilenko Е.V., Magarill Yu.А., Khobotkova Е.L. Molecular-genetic aspects of endometrial cancer with neuroendocrine disorders. Siberian Journal of Oncology. 2007; Suppl.1: 5–8. [in Russian]
13. Butrova S.А. Metabolic syndrome: pathogenesis, clinical symptoms, diagnosis and approaches to treatment. Russian Medical Journal. 2001; 2: 56–62. [in Russian]
14. Wang C., Wang X., Gong G., Ben Q., Qiu W., Chen Y., Li G., Wang L. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2012 Apr 1; 130 (7): 1639–48. doi: 10.1002/ijc.26165.
15. Spirina L.V., Kondakova I.V., Usynin Е.А., Kolomiets L.А., Vintizenko S.I., Bochkareva N.V., Chernyshova А.L. Proteasome activity and concentration of growth factors in renal, bladder and endometrial carcinomas. Russian Journal of Oncology. 2010; 1: 23–25. [in Russian]
16. Berstein L.M., Chernobrovkina A.Ye., Gamayunova V.B., Vasilyev D.A., Kovalevsky A.Yu., Maximov S.Ya., Chepik O.F., Gershfeld E.D. Aromatase levels, estrogen concentration in tumor versus course of endometrial cancer. Problems in Oncology. 2003; 49 (1): 55–59. [in Russian]
17. Zadionchenko V.S., Adasheva Т.V., Demicheva О.Yu., Poryvkina О.N. Metabolic syndrome: therapeutical options and prospects. Consillium Medicum. 2005; 7 (9): 725–733. [in Russian]
18. Kuramoto H., Jobo Т., Ohkawara S., Hata H. Endometrial carcinoma: one disease? Endometr. Cancer. 2000; 10: 69–70.
19. Kondakova I.V., Spirina L.V., Shashova Е.Е., Koval V.D., Chernyshova A.L., Slonimskaya Е.М. Proteasome activity in tumors of the female reproductive system. Bioorganic chemistry. 2012; 38 (1): 106. [in Russian]
20. Pankov Yu.А. Revolutionary changes in endocrinology. Problems in Endocrinology. 2005; 51 (6): 3–8. [in Russian]
21. Burroughs K.D., Dunn S.E., Barrett J.С., Taylor J.A. Insulin-like growth factor I: a key regulator of human cancer risk. J Natl Cancer Inst. 1999 Apr 7; 91 (7): 579–81.
22. Bershtein L.М. Endocrinology of hormone-dependent tumors. Problems in Oncology. 2002; 48 (4): 496–503. [in Russian]
23. Bershtein L.М. Epidemiology, pathogenesis and prevention of endometrial cancer: stability or evolution? Practical Oncology. 2004. 5 (1): 1–8. [in Russian]
24. Tsallagova Е.V., Prilepskaya V.N. The role of the reduction in overweight in restoring the function of the female reproductive system. Gynecology. 2005; 7 (1): 51–53. [in Russian]
25. Alcazar J.L., Galan M.J., Jurado М., Lopez-Garcia G. Intratumoral blood flow analysis in endometrial carcinoma: correlation with tumor characteristics and rise for recurrence. Gynecol Oncol. 2002 Feb; 84 (2): 258–62.
26. Petunina N.А. Modern approaches to the treatment of obesity. Gynecology. 2002; 4 (1): 32–35. [in Russian]
27. Kobalova Zh.D., Tolkacheva V.V. Metabolic syndrome: treatment principals. Russian Medical Journal. 2005: 7: 451–458. [in Russian]
28. Merabishvili V.М., Safronnikova N.R. Malignant neoplasms of female genital organs (morbidity). The Abstr. Book of the IX Russ. Conf. of Oncologists «Hormone- Dependent Tumors». St. Petersburg; 2002: 61–63. [in Russian]
29. Kiselyev V.I., Muzheinik Е.L. The role of estrogen metabolites in carcinogenesis of reproductive organs. Obstetrics and gynecology. 2006; 3: 55–59. [in Russian]
30. Session D.R., Kalli K.R., Tummon I.S., Damario M.A., Dumesic D.A. Treatment of atypical endometrial hyperplasia with aninsulin-sensitizing agent. Gynecol Endocrinol. 2003 Oct; 17 (5): 405–7.
31. Yamada K.M., Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci. 2001 Jul; 114 (Pt 13): 2375–82.
32. Horn L.C., Schmidt D. Recommendations for the oncologic pathology report and morphologic factors associated with prognosis in endometrial carcinoma. Zentralbl Gynakol. 2002 Jan; 124 (1): 36–44.
33. Barinov V.V. The world standards and treatment outcomes for endometrial cancer. The 5-th annual Russian Cancer Conference: Conference Proceedings. Moscow; 2002: 82– 83. [in Russian]
34. Butrova S.А. Treatment of obesity. Moscow; 2002, 21 p. [in Russian]
35. Sokolov Е.I., Mironova Е.K., Zykova А.А. Hormone disintegration in metabolic syndrome. Clinical Medicine. 2008; 86 (2): 52–56. [in Russian]
36. Kalli K.R., Chen B.K., Bale L.K., Gernand E., Overgaard M.T., Oxvig C., Cliby W.A., Conover C.A. Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells. Int J Cancer. 2004 Jul 10; 110 (5): 633– 40.
37. Lections on gynecological oncology / Eds. М.I. Davydov, V.V. Kuznetsov, V.M. Nechushkina. Moscow; 2009, 432 p. [in Russian]
38. Zadionchenko V.S., Adasheva Т.V., Demicheva О.Yu., Poryvkina О.N. Metabolic syndrome: therapeutic options and prospects. Consillium Medicum. 2005; 7 (9): 725– 733. [in Russian]
Review
For citations:
Chernyshova A.L., Kolomiets L.A., Saprina T.V., Gonchikova O.E., Koshchevets T.Yu. CURRENT APPROACHES TO THE TREATMENT OF METABOLOC SYNDROME IN PATIENTS WITH ENDOMETARIAL HYPERPLASIA AND CANCER. Siberian journal of oncology. 2016;15(5):73-81. (In Russ.) https://doi.org/10.21294/1814-4861-2016-15-5-73-81
Views:
850
Email this article 
